Switch to:
More From Other Websites
Momenta to Regain Rights to Humira Biosimilar from Shire Sep 28 2016
Blog Coverage Shire PLC Terminates Collaboration Agreement with Momenta Pharma for M923 Sep 28 2016
2 growing FTSE 100 firms to consider now Sep 28 2016
Third Value Fund Avenue Buys 3 Stocks in 3rd Quarter Sep 27 2016
Shire plc downgraded by HSBC Securities Sep 26 2016
Do today’s results make this company a better buy than Shire plc? Sep 26 2016
Billionaire James Dinan’s York Capital Initiated Stakes in These Companies Sep 26 2016
Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest Sep 23 2016
Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest Sep 23 2016
Shire raises eyebrows with stunning debut Sep 23 2016
Shire raises eyebrows with stunning debut Sep 23 2016
Shire Closes Public Offering of ... Sep 23 2016
SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Sep 23 2016
Shire Closes Public Offering of Senior Notes Sep 23 2016
SHIRE TO SHOWCASE CONTINUED ... Sep 23 2016
Shire to Showcase Continued Innovation and Leadership in Immune Deficiencies During European Society... Sep 23 2016
​The bobble-head doll in the office of Shire CEO Flemming Ornskov Sep 22 2016
Corporations Have Been Issuing Larger Bonds (BUD, SHPG) Sep 21 2016
'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs Sep 21 2016
SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Sep 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK